If you are wondering whether Agilent Technologies at around US$112.75 is starting to look attractively priced, the recent ...

Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to ...

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in ...

Agilent Technologies (A) has been drawing attention after recent share price weakness, with the stock down about 10% over the ...

Biocare has been under the stewardship of VC firms Excellere Partners and GHO Capital since 2021, achieving revenue of $90m ...

By Sahil Pandey and Bageshri Banerjee March 9 (Reuters) - Life sciences firm Agilent Technologies said on Monday that it will ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument ...

Agilent Technologies has agreed to acquire Resolution Bioscience for up to $695 million, the companies said Tuesday, in a deal intended to expand the buyer’s precision medicine offerings by ...

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro ...

Agilent to buy clinical and research pathology solutions leader, Biocare Medical for $950 million: Santa Clara, California Wednesday, March 11, 2026, 10:00 Hrs [IST] Agilent Techn ...

Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...